SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Regeneron Pharmaceuticals, Inc. Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$86.25M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.75% | 13.16K shares | 20.01M | $688.87 | 125.20K |
| Q2 2022 | share | Decrease | -26.90% | -41.23K shares | -40.81M | $591.13 | 112.04K |
| Q1 2022 | share | Decrease | -23.22% | -46.35K shares | -21.21M | $698.42 | 153.27K |
| Q4 2021 | share | Increase | +83.72% | 90.97K shares | 62.50M | $642.51 | 199.63K |
| Q3 2021 | share | Increase | +94.60% | 52.82K shares | 34.57M | $605.18 | 108.65K |
| Q2 2021 | share | Decrease | -33.39% | -27.99K shares | -8.47M | $558.54 | 55.83K |
| Q1 2021 | share | Decrease | -27.66% | -32.05K shares | -16.32M | $473.14 | 83.82K |
| Q4 2020 | share | Increase | +11.29% | 11.75K shares | -2.30M | $483.11 | 115.88K |
| Q3 2020 | share | Increase | +5.79% | 5.70K shares | -3.09M | $559.78 | 104.12K |
| Q2 2020 | share | Decrease | -16.05% | -18.81K shares | 4.13M | $623.65 | 98.42K |
| Q1 2020 | share | Decrease | -19.99% | -29.29K shares | 2.22M | $488.29 | 117.24K |
| Q4 2019 | share | Increase | +241.22% | 103.58K shares | 43.10M | $375.48 | 146.53K |
| Q3 2019 | share | Decrease | -22.55% | -12.50K shares | -5.44M | $277.4 | 42.94K |
| Q2 2019 | share | Decrease | -58.06% | -76.75K shares | -36.92M | $313 | 55.44K |
| Q1 2019 | share | Increase | +0.95% | 1.24K shares | 5.37M | $410.62 | 132.19K |
| Q4 2018 | share | Increase | +36.94% | 35.32K shares | 10.27M | $373.5 | 130.95K |
| Q3 2018 | share | Increase | +118.70% | 51.90K shares | 23.55M | $404.04 | 95.62K |
| Q2 2018 | share | Increase | +10.08% | 4.00K shares | 1.40M | $344.99 | 43.72K |
| Q1 2018 | share | Decrease | -7.04% | -3.00K shares | -2.38M | $344.36 | 39.72K |
| Q4 2017 | share | Decrease | -4.38% | -1.95K shares | -3.91M | $375.96 | 42.73K |
| Q3 2017 | share | Decrease | -4.49% | -2.1K shares | -2.99M | $447.12 | 44.68K |
| Q2 2017 | share | Decrease | -9.10% | -4.68K shares | 3.03M | $491.14 | 46.78K |
| Q1 2017 | share | Decrease | -11.40% | -6.62K shares | -1.38M | $387.51 | 51.47K |
| Q4 2016 | share | Decrease | -13.11% | -8.76K shares | -5.55M | $367.09 | 58.09K |
| Q3 2016 | share | Decrease | -7.09% | -5.1K shares | 1.74M | $402.02 | 66.86K |
| Q2 2016 | share | Decrease | -4.13% | -3.1K shares | -1.92M | $349.23 | 71.96K |
| Q1 2016 | share | Decrease | -9.41% | -7.8K shares | -17.92M | $360.44 | 75.06K |